Pml represses tumour progression through inhibition of mTOR-Reference-Cited by-同舟云学术

Pml represses tumour progression through inhibition of mTOR

Published:2011-03-08 Issue:5 Volume:3 Page:249-257
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Bernardi Rosa¹²,Papa Antonella¹,Egia Ainara¹,Coltella Nadia¹³,Teruya‐Feldstein Julie⁴,Signoretti Sabina⁵,Pandolfi Pier Paolo¹

Affiliation:

1. Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Division of Genetics, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

2. Current address: Division of Molecular Oncology, San Raffaele Scientific Institute, Via Olgettina 60, Milano 20132, Italy

3. Division of Molecular Oncology, San Raffaele Scientific Institute, Milano, Italy

4. Department of Pathology, Memorial Sloan‐Kettering Cancer Center, Sloan‐Kettering Institute, New York, NY, USA

5. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/emmm.201100130

Reference22 articles.

1. PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR

2. The Two TORCs and Akt

3. Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis

4. Sarcomatoid Differentiation in Renal Cell Carcinoma

5. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma;EMBO Molecular Medicine;2024-05-10

2. PML Nuclear bodies: the cancer connection and beyond;Nucleus;2024-02-27

3. PML and PML-like exonucleases restrict retrotransposons in jawed vertebrates;Nucleic Acids Research;2023-03-13

4. PML and PML-like exonucleases restrict retrotransposons in jawed vertebrates;2022-07-30

5. Golgi phosphoprotein 3 promotes angiogenesis and sorafenib resistance in hepatocellular carcinoma via upregulating exosomal miR-494-3p;Cancer Cell International;2022-01-24